Variation in methods of predicting adult height for children with idiopathic short stature
- PMID: 20974789
- PMCID: PMC3793344
- DOI: 10.1542/peds.2009-3649
Variation in methods of predicting adult height for children with idiopathic short stature
Abstract
Objective: Recombinant human growth hormone (GH) is approved for treatment of children with idiopathic short stature, and endocrinologists often depend on algorithms to predict adult height. Because algorithm performance often is included in treatment decisions, we sought to evaluate agreement among height prediction formulas.
Methods: We identified 3 commonly used algorithms for height prediction, the Bayley-Pinneau, Roche-Wainer-Thissen, and Khamis-Roche methods. We constructed simulated samples of children with typical distributions of ages, heights, weights, bone ages, and parental heights seen in patients with idiopathic short stature, and we applied the algorithms to the simulated sample to determine whether predicted adult height was <160 cm for boys or <150 cm for girls (<1.2nd height percentiles for adults).
Results: We found substantial disagreement among algorithms in the proportions of simulated cases with predicted adult heights of <1.2nd percentile, a cutoff value that may influence GH treatment decisions. With the Bayley-Pinneau formula, 43% of boys and 81% of girls had predicted adult heights below this threshold; with the Khamis-Roche method, only 3% of boys and 0.2% of girls had predicted heights of <1.2nd percentile. Roche-Wainer-Thissen predictions were between those values. Overall agreement of the methods was poor (κ = 0.21) for boys and negative for girls.
Conclusions: Wide variation exists among formulas used to predict adult heights. Because these algorithms may be used in decisions regarding whether to initiate GH treatment and assessment of the efficacy of GH in research trials, it is important for parents, pediatricians, and investigators to recognize the considerable variation involved in height predictions.
Figures

Similar articles
-
A valuable improvement of adult height prediction methods in short normal children.Horm Res. 1997;48(4):184-90. doi: 10.1159/000185511. Horm Res. 1997. PMID: 9378465 Clinical Trial.
-
Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction.J Pediatr. 1990 Dec;117(6):886-91. doi: 10.1016/s0022-3476(05)80127-1. J Pediatr. 1990. PMID: 2246686
-
Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency.Endocr Res. 2021 Aug;46(3):140-147. doi: 10.1080/07435800.2021.1916029. Epub 2021 Apr 26. Endocr Res. 2021. PMID: 33900130
-
Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.Arch Pediatr Adolesc Med. 2002 Mar;156(3):230-40. doi: 10.1001/archpedi.156.3.230. Arch Pediatr Adolesc Med. 2002. PMID: 11876666
-
Growth hormone treatment of idiopathic short stature.Horm Res. 1996;46(4-5):208-14. doi: 10.1159/000185025. Horm Res. 1996. PMID: 8950623 Review.
Cited by
-
Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology.J Clin Endocrinol Metab. 2024 Jan 18;109(2):e442-e454. doi: 10.1210/clinem/dgad417. J Clin Endocrinol Metab. 2024. PMID: 37450564 Free PMC article. Review.
-
A retrospective study of recombinant human growth hormone in the treatment of school-aged pediatric patients with idiopathic short stature.Medicine (Baltimore). 2024 Nov 15;103(46):e40545. doi: 10.1097/MD.0000000000040545. Medicine (Baltimore). 2024. PMID: 39560519 Free PMC article.
-
Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.Curr Opin Pediatr. 2017 Aug;29(4):466-471. doi: 10.1097/MOP.0000000000000505. Curr Opin Pediatr. 2017. PMID: 28525404 Free PMC article. Review.
-
Growth failure: 'idiopathic' only after a detailed diagnostic evaluation.Endocr Connect. 2021 Mar;10(3):R125-R138. doi: 10.1530/EC-20-0585. Endocr Connect. 2021. PMID: 33543731 Free PMC article. Review.
-
Adult height prediction by bone age determination in children with isolated growth hormone deficiency.Endocr Connect. 2020 May;9(5):370-378. doi: 10.1530/EC-20-0090. Endocr Connect. 2020. PMID: 32268296 Free PMC article.
References
-
- (FDA) FaDA. [Accessed 10/31/2005];FDA Talk Paper: FDA Approves Humatrope for Short Stature. http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html. Published 2003.
-
- Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med. 2004;158(2):108–110. - PubMed
-
- Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(7):3140–3148. - PubMed
-
- Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, et al. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr. 2005;146(1):45–53. - PubMed
-
- Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2007;(3):CD004440. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical